Spa-RQ: an Image Analysis Tool to Visualise and Quantify Spatial Phenotypes Applied to Non-Small Cell Lung Cancer

[1]  Huafeng Liu,et al.  Direct delineation of myocardial infarction without contrast agents using a joint motion feature learning architecture , 2018, Medical Image Anal..

[2]  Avi Ma'ayan,et al.  Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks , 2018, Science Signaling.

[3]  Leena Latonen,et al.  Comparative analysis of tissue reconstruction algorithms for 3D histology , 2018, Bioinform..

[4]  Steven J. M. Jones,et al.  Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.

[5]  O. Kallioniemi,et al.  Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras‐driven lung tumours , 2018, The Journal of pathology.

[6]  Triantafyllos Stylianopoulos,et al.  Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. , 2018, Trends in cancer.

[7]  R. Stephens,et al.  Differential Effector Engagement by Oncogenic KRAS. , 2018, Cell reports.

[8]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[9]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[10]  Kelly Quek,et al.  TRACERx: Tracking tumor evolution to impact the course of lung cancer. , 2017, The Journal of thoracic and cardiovascular surgery.

[11]  Lassi Paavolainen,et al.  Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis , 2017, Scientific Reports.

[12]  Adrian V. Lee,et al.  Platform for Quantitative Evaluation of Spatial Intratumoral Heterogeneity in Multiplexed Fluorescence Images. , 2017, Cancer research.

[13]  David B. A. Epstein,et al.  Hyper-Stain Inspector: A Framework for Robust Registration and Localised Co-Expression Analysis of Multiple Whole-Slide Images of Serial Histology Sections , 2017, Scientific Reports.

[14]  David B. A. Epstein,et al.  Simultaneous automatic scoring and co‐registration of hormone receptors in tumor areas in whole slide images of breast cancer tissue slides , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  Nicolai J. Birkbak,et al.  Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.

[16]  Adam A. Margolin,et al.  Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis. , 2017, Cell reports.

[17]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[18]  O. Kallioniemi,et al.  Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1. , 2017, Cell reports.

[19]  J. Gray,et al.  Multiplexed imaging reveals heterogeneity of PI3K/MAPK network signaling in breast lesions of known PIK3CA genotype , 2016, Breast Cancer Research and Treatment.

[20]  B. Chan,et al.  Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. , 2015, Translational lung cancer research.

[21]  A. Berns,et al.  Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma , 2014, Proceedings of the National Academy of Sciences.

[22]  C. Rommel,et al.  PI3K and cancer: lessons, challenges and opportunities , 2014, Nature Reviews Drug Discovery.

[23]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[24]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[25]  Valerie M. Weaver,et al.  A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.

[26]  Pier Paolo Pandolfi,et al.  The PTEN–PI3K pathway: of feedbacks and cross-talks , 2008, Oncogene.

[27]  Michael B Yaffe,et al.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. , 2007, Cancer cell.

[28]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[29]  Jie Tian,et al.  Multi-modal Medical Image Registration Based on Adaptive Combination of Intensity and Gradient Field Mutual Information , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[30]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[31]  A. Ruifrok,et al.  Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.